
Analytica Chimica Acta, Год журнала: 2025, Номер unknown, С. 344256 - 344256
Опубликована: Май 1, 2025
Язык: Английский
Analytica Chimica Acta, Год журнала: 2025, Номер unknown, С. 344256 - 344256
Опубликована: Май 1, 2025
Язык: Английский
Deleted Journal, Год журнала: 2025, Номер 2(1)
Опубликована: Март 9, 2025
Язык: Английский
Процитировано
1Journal of Inorganic and Organometallic Polymers and Materials, Год журнала: 2025, Номер unknown
Опубликована: Март 7, 2025
Язык: Английский
Процитировано
0Nano TransMed, Год журнала: 2025, Номер unknown, С. 100080 - 100080
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
0Journal of Water Process Engineering, Год журнала: 2025, Номер 74, С. 107870 - 107870
Опубликована: Май 1, 2025
Язык: Английский
Процитировано
0International Journal of Nanomedicine, Год журнала: 2025, Номер Volume 20, С. 6043 - 6057
Опубликована: Май 1, 2025
Phototherapy have gained significant traction in the treatment of tumors. However, successful implementation these therapies relies on photosensitizers with superior properties and precise guidance mechanisms. In this study, we introduce an innovative method for surface modification titanium dioxide (TiO2) nanoparticles through HRP-catalyzed covalent incorporation Mn(II) chelate (Mn-Dopa) dopamine. This extends TiO2 nanoparticels' light absorption from ultraviolet to near-infrared (NIR) range, endowing MRI-guided phototherapy capabilities. The resulting nanotheranostics system, TiO2@PDA-MnDopa, demonstrated over 5-fold enhanced relaxivity compared monomeric MnDopa exhibited synergistic effects upon 808 nm laser excitation, a photothermal conversion efficiency 15.91%. vitro vivo pharmacodynamics studies showed that TiO2@PDA-MnDopa good safety HSC3 cell line corresponding tumor-bearing mice, while effectively inhibiting tumor growth under excitation. multifunctional nanotheranostic, integrating high PTT/PDT MR imaging-guided phototherapy, holds great potential applications early diagnosis, noninvasive treatment, prognostic evaluation oral squamous carcinoma.
Язык: Английский
Процитировано
0Cancer Cell International, Год журнала: 2025, Номер 25(1)
Опубликована: Май 25, 2025
Osteosarcoma (OS), chondrosarcoma (CHS), and Ewing sarcoma (EWS) are the main types of bone cancer (BC). OS is most common BC in this group. It children older people, especially their long bones. Treatments for sarcomas tumors have slowly improved, so researchers began looking into additional alternative approaches to standard therapies. Therefore, ability precisely manipulate metallic nanoparticles (MNPs)' form, size, charge, surface modification makes them very useful treating cancer. However, due biocompatibility possible toxicity MNPs, MNP has limits clinical use BC. green synthesis MNPs achieved by bio-reducing ions, which results creation NPs, using living entities or extracts. Green derived from natural sources provide a secure environmentally responsible solution. Benefits include tailored medicine delivery biocompatibility. reduce damage healthy cells while improving targeting cells. In study, we reviewed how different synthesized methods can help treat various This work usual way making BC, problems with benefits future uses synthetic
Язык: Английский
Процитировано
0Analytica Chimica Acta, Год журнала: 2025, Номер unknown, С. 344256 - 344256
Опубликована: Май 1, 2025
Язык: Английский
Процитировано
0